Last reviewed · How we verify

NCT04807985

Feasibility of Remote JVP Assessment

Completed Last updated 23 March 2022
What this trial tests

trial testing JVPHome and ultrasound in Congestive Heart Failure in 24 participants. Completed in 1 October 2021.

Timeline
1 January 2021
Primary endpoint
30 August 2021
1 October 2021

Quick facts

Lead sponsorEastern Regional Health Authority
StatusCompleted
Study typeOBSERVATIONAL
Enrollment24
Start date1 January 2021
Primary completion30 August 2021
Estimated completion1 October 2021
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

Eastern Regional Health Authority

Who can join

18 and older, any sex, with Congestive Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The JVPHome is a novel medical device that utilizes machine vision in order to facilitate assessment of jugular venous pressure (JVP) height relative to the sternal angle with the ultimate goal of enabling remote JVP monitoring. The current study aims to evaluate the ability of the JVPHome to enable remote identification of JVP height relative to ultrasound among congestive heart failure (CHF) patients when the device is applied by the study team in the clinic.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Congestive Heart Failure

Currently open trials in the same condition.

Other Eastern Regional Health Authority trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04807985.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing